Scran Biotrans Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.46 M
- Revenue Growth -4.54%
- Profit Growth 59.93%
- Ebitda 8.27%
- Net Worth 3.55%
- Total Assets -23.18%
About Scran Biotrans
Scran Biotrans Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 October 2013 and has a history of 11 years and four months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Environment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹8.46 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanket Patel and Kamalaben Patel serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U37100GJ2013PTC077015
-
Company No.
077015
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Oct 2013
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Scran Biotrans?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanket Patel
|
Director | 01-Oct-2013 | Current |
|
Kamalaben Patel
|
Director | 01-Oct-2013 | Current |
Financial Performance of Scran Biotrans.
Scran Biotrans Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.54% decrease. The company also saw a substantial improvement in profitability, with a 59.93% increase in profit. The company's net worth moved up by a moderate rise of 3.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Scran Biotrans?
In 2023, Scran Biotrans had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹8.46 M
Charges Breakdown by Lending Institutions
- Vijaya Bank : 0.69 Cr
- Hdfc Bank Limited : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2014 | Vijaya Bank | ₹1.88 M | Satisfied |
| 29 May 2014 | Hdfc Bank Limited | ₹1.13 M | Satisfied |
| 29 May 2014 | Hdfc Bank Limited | ₹0.45 M | Satisfied |
| 07 Dec 2013 | Vijaya Bank | ₹5.00 M | Satisfied |
How Many Employees Work at Scran Biotrans?
Unlock and access historical data on people associated with Scran Biotrans, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Scran Biotrans, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Scran Biotrans's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
